336 related articles for article (PubMed ID: 3561441)
1. Dantrolene sodium is able to reduce the resting ionic [Ca2+]i in muscle from humans with malignant hyperthermia.
López JR; Medina P; Alamo L
Muscle Nerve; 1987 Jan; 10(1):77-9. PubMed ID: 3561441
[TBL] [Abstract][Full Text] [Related]
2. Myoplasmic free [Ca2+] during a malignant hyperthermia episode in swine.
López JR; Allen PD; Alamo L; Jones D; Sreter FA
Muscle Nerve; 1988 Jan; 11(1):82-8. PubMed ID: 3340102
[TBL] [Abstract][Full Text] [Related]
3. Dantrolene prevents the malignant hyperthermic syndrome by reducing free intracellular calcium concentration in skeletal muscle of susceptible swine.
Lopez JR; Allen P; Alamo L; Ryan JF; Jones DE; Sreter F
Cell Calcium; 1987 Oct; 8(5):385-96. PubMed ID: 3427616
[TBL] [Abstract][Full Text] [Related]
4. Effects of dantrolene on myoplasmic free [Ca2+] measured in vivo in patients susceptible to malignant hyperthermia.
Lopez JR; Gerardi A; Lopez MJ; Allen PD
Anesthesiology; 1992 May; 76(5):711-9. PubMed ID: 1575338
[TBL] [Abstract][Full Text] [Related]
5. Malignant hyperthermia: responses of skeletal muscles to general anesthetics.
Gallant EM; Ahern CP
Mayo Clin Proc; 1983 Nov; 58(11):758-63. PubMed ID: 6355673
[TBL] [Abstract][Full Text] [Related]
6. The effects of extracellular magnesium on myoplasmic [Ca2+] in malignant hyperthermia susceptible swine.
Lopez JR; Sanchez V; Lopez I; Ryan JF; Mendoza M; Sreter FA; Allen PD
Anesthesiology; 1990 Jul; 73(1):109-17. PubMed ID: 2360720
[TBL] [Abstract][Full Text] [Related]
7. Dantrolene reduces myoplasmic free [Ca2+] in patients with malignant hyperthermia.
López JR; López M; Allen P
Acta Cient Venez; 1990; 41(2):135-7. PubMed ID: 2135562
[No Abstract] [Full Text] [Related]
8. Effects of azumolene on normal and malignant hyperthermia-susceptible skeletal muscle.
Sudo RT; Carmo PL; Trachez MM; Zapata-Sudo G
Basic Clin Pharmacol Toxicol; 2008 Mar; 102(3):308-16. PubMed ID: 18047479
[TBL] [Abstract][Full Text] [Related]
9. Deficient function of the sarcoplasmic reticulum in patients susceptible to malignant hyperthermia.
Condrescu M; López JR; Medina P; Alamo L
Muscle Nerve; 1987; 10(3):238-41. PubMed ID: 2951595
[TBL] [Abstract][Full Text] [Related]
10. [Malignant hyperthermia].
Schulte-Sasse U; Eberlein HJ
Anaesthesist; 1983 Apr; 32(4):141-57. PubMed ID: 6349413
[TBL] [Abstract][Full Text] [Related]
11. EU 4093 decreases intracellular [Ca2+] in skeletal muscle fibers from control and malignant hyperthermia-susceptible swine.
Allen PD; López JR; Sánchez V; Ryan JF; Sreter FA
Anesthesiology; 1992 Jan; 76(1):132-8. PubMed ID: 1729917
[TBL] [Abstract][Full Text] [Related]
12. Malignant hyperthermia: current perspectives.
Felice-Johnson J; Sudds T; Bennett G
Am J Hosp Pharm; 1981 May; 38(5):646-51. PubMed ID: 7282692
[TBL] [Abstract][Full Text] [Related]
13. Intracellular calcium homeostasis in human primary muscle cells from malignant hyperthermia-susceptible and normal individuals. Effect Of overexpression of recombinant wild-type and Arg163Cys mutated ryanodine receptors.
Censier K; Urwyler A; Zorzato F; Treves S
J Clin Invest; 1998 Mar; 101(6):1233-42. PubMed ID: 9502764
[TBL] [Abstract][Full Text] [Related]
14. Do we foresee new emerging drugs to treat malignant hyperthermia?
Just KS; Gerbershagen MU; Grensemann J; Wappler F
Expert Opin Emerg Drugs; 2015 Jun; 20(2):161-4. PubMed ID: 25736705
[TBL] [Abstract][Full Text] [Related]
15. Verapamil is not a therapeutic adjunct to dantrolene in porcine malignant hyperthermia.
Gallant EM; Foldes FF; Rempel WE; Gronert GA
Anesth Analg; 1985 Jun; 64(6):601-6. PubMed ID: 4003778
[TBL] [Abstract][Full Text] [Related]
16. [Dantrolene. Pharmacological and therapeutic aspects].
Gerbershagen MU; Fiege M; Krause T; Agarwal K; Wappler F
Anaesthesist; 2003 Mar; 52(3):238-45. PubMed ID: 12666006
[TBL] [Abstract][Full Text] [Related]
17. Dantrolene--a review of its pharmacology, therapeutic use and new developments.
Krause T; Gerbershagen MU; Fiege M; Weisshorn R; Wappler F
Anaesthesia; 2004 Apr; 59(4):364-73. PubMed ID: 15023108
[TBL] [Abstract][Full Text] [Related]
18. Malignant hyperthermia: a dilemma for the cardiac surgeon.
Landymore RW; Allen C; Johnstone D; Wood J
Can J Surg; 1987 May; 30(3):209-11. PubMed ID: 3495323
[TBL] [Abstract][Full Text] [Related]
19. Malignant hyperthermia.
Moore JL; Rice EL
Am Fam Physician; 1992 May; 45(5):2245-51. PubMed ID: 1575119
[TBL] [Abstract][Full Text] [Related]
20. Halothane induced porcine malignant hyperthermia reversed by dantrolene.
Alitalo I; Schulman A
Nord Vet Med; 1983; 35(5-6):239-42. PubMed ID: 6889129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
